← Leaderboards
Suphamai Bunnapradist
University Of California Los Angeles
$5,856,919
Attributed
$5,856,919
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2014–21$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,443,891 · 2
FDA$2,413,028 · 1
By mechanism
U19$3,443,891 · 2
U01$2,413,028 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Elaine F Reed$20,661,923
- Roger Detels$99,398,401
- Shehnaz Khursheed Hussain$5,082,198
- Jerzy W. Kupiec-Weglinski$24,134,558
- Robert L Modlin$53,861,964
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseTransplant RecipientsCytomegalovirusInfectionMorbidity - Disease RateMortalityKidney TransplantationData ManagementAdverse EventEnrollmentBloodCaliforniaDatabasesData CollectionComputer SoftwareClinical ResearchAccelerationClinical ProtocolsClinical PracticeClinical TrialsClinical Trials Data Monitoring CommitteesBiopsy SpecimenCollaborationsAllografting
Grant awards (8)
Core A: Clinical$347,140
U19 · FY2021 · AI · contact PI
Core A: Clinical$869,489
U19 · FY2020 · AI · contact PI
Core A: Clinical$444,900
U19 · FY2020 · AI · contact PI
Core A: Clinical$587,820
U19 · FY2019 · AI · contact PI
Core A: Clinical$596,246
U19 · FY2018 · AI · contact PI
Core A: Clinical$598,296
U19 · FY2017 · AI · contact PI
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Responses$1,413,028
U01 · FY2015 · FD · contact PI
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Responses$1,000,000
U01 · FY2014 · FD · contact PI